Rothman Orthopedic Institute

Website
100 E 77th St
New York, NY 10075

Rothman Orthopedic Institute in New York, NY is led by Dr. Eric L. Grossman, a fellowship trained and board certified orthopedic surgeon specializing in hip and knee joint replacement surgery. With a focus on providing solutions for joint pain, Dr. Grossman offers a range of procedures including total knee replacement, robotic knee replacement, outpatient knee replacement, partial knee replacement, complex revision knee replacement, knee arthroscopy, anterior hip replacement, robotic hip replacement, outpatient hip replacement, complex revision hip replacement, and hip fracture treatment.

Patients of Rothman Orthopedic Institute praise Dr. Grossman for his clear explanations, personalized attention, and expertise in helping them get back to an active lifestyle. The institute also offers patient resources, educational videos, and insurance acceptance to ensure a seamless experience for patients seeking orthopedic care.

Generated from the website

Own this business?
See a problem?

You might also like

Psychiatrists and psychoanalysts, Internal medicine practitioners

Frank J Schwab, MD - Northwell Health

Professionally, I am highly motivated and dedicated to making significant contributions to advancing Neuroradiology research and practice. Specifically, I have developed a special focus on neurological molecular imaging, with an emphasis on the advancement of brain PET/MRI and hybrid imaging techniques in dementia and neurodegenerative disease. I was awarded the Foundation of the ASNR 2021 Boerger Research Fund for Alzheimer s Disease and Neurocognitive Disorders for the project [18F] PI-2620 in Primary Progressive Aphasia (Franceschi AM, PI), with the goal of characterizing biodistribution of abnormal tau accumulation in PPA subtypes using the novel second generation tracer PI-2620 and correlating these findings with clinical disease severity and neurodegeneration. I am also PI for the project Utility of [18F] PI-2620 as Universal Biomarker for the A/T/N Classification of Dementia and Neurodegenerative Disease , which aims to establish the efficacy of PI-2620 as a single, universal biomarker for the A/T/N classification scheme of dementia, with the eventual goal of its use in descriptive classification, patient selection and target engagement assessment in disease-modifying clinical treatment trials. I contribute as a co-Investigator on the study A Life Course Approach to Integrating Trauma and Cognitive Aging: A Cohort of 9/11 Responders, which is part of the World Trade Center (WTC) responders aging program (NIH R01 AG049953; Clouston, PI). This research focuses on PTSD and WTC exposures as risk factors for cognitive dysfunction and decline in a prospective cohort of responders, alongside changes in -amyloid, tau deposition, and neurodegeneration. These varied experiences have allowed me to understand the characterization of non-Alzheimer s tauopathies, and have improved my analytical expertise to apply this knowledge to studying Alzheimer s disease and related neurocognitive disorders. In addition to multiple scientific publications on these topics, I am lead editor of the textbook Hybrid PET/MR Neuroimaging: A Comprehensive Approach (Springer Nature, 2022).
United StatesNew YorkNew YorkRothman Orthopedic Institute